Author Archives: admin

Ribociclib Can Add Almost 1 Year to Overall Survival for Patients With Aggressive Form of Breast Cancer – Pharmacy Times

Ribociclib with endocrine therapy was found to increase the median overall survival of patients with HR+/HER2- advanced breast cancer with visceral metastases to nearly 5 years. Ribociclib (Kisqali; Novartis) was found to add nearly 1 year to overall survival (OS) in patients with aggressive hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (aBC). In a pooled exploratory analysis of the MONALEESA phase 3 program presented at the 2022 European Society of Medical Oncology Congress (ESMO), researchers found that first-line treatment with ribociclib and endocrine therapy increased the median OS by 10.6 months, compared to endocrine therapy alone.

Biosimilars Global Market Opportunities and Strategies Report 2022: Long-term Forecast to 2026 & 2031 – ResearchAndMarkets.com – Business Wire

DUBLIN--(BUSINESS WIRE)--The "Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering. The global biosimilars market reached a value of nearly $11,418.9 million in 2021, having grown at a compound annual growth rate (CAGR) of 34.8% since 2016. The market is expected to grow from $11,418.9 million in 2021 to $25,985.2 million in 2026 at a rate of 17.3%

Lumos Pharma to Participate in the HC Wainwright 24th Annual Global Investment Conference – GuruFocus.com

AUSTIN, Texas, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (LUMO, Financial), a biopharmaceutical company advancing a novel oral therapeutic candidate, LUM-201, through Phase 2 clinical trials for Pediatric Growth Hormone Deficiency (PGHD), announced that the Company will present and host one-on-one meetings at the H.C

The Global External Fixation Systems Market to Witness Growth at a CAGR of 5.62% During the Study Period (20192027) | DelveInsight – Yahoo Finance

DelveInsight Business Research LLP The external fixation systems market is anticipated to surge due to the factors such as the increasing prevalence of degenerative bone disorders such as osteoporosis and osteoarthritis. Another prominent factor contributing to product demand growth is the surge in the global increase in the geriatric population base, who form a major section of the patient pool of fractures due to frequent falls and degenerative bone diseases. The increasing focus on product development activities with the latest innovation with respect to external fixators also plays a key role in establishing a positive growth trend in the external fixation systems market during the forecast period from 2022 to 2027.

Hasbulla Magomedov: Who is Hasbulla? Why is the Russian an online sensation? Whats his medical condition? – The Scotsman

Despite being small in stature, Hasbulla boasts a huge online fan base with three million followers on Instagram. Recently, Hasbulla made headlines after taking a trip down under to Australia as part of his international tour, he said: I cant wait to see all my Aussie fans and visit these amazing cities, I come from a tiny town in Russia, so I am looking forward to experiencing a different culture. I also know there are kangaroos, I would like to meet them.

$250 million Peyton Manning was accused of using doping drug HGH by his former pharmacist and having it mailed… – The Sportsrush

NFL icon Peyton Manning was accused of using performance-enhancing drugs by his former pharmacist. However, the league cleared him after a detailed 7-month long investigation

Home-run stud Aaron Judge is doing it the right way we think – Chicago Sun-Times

Home runs are the coolest part of baseball. The run scored is important. But the emotional thrill is witnessing the launching of something out of the boundaries of the game and into the real world, breaking down the barrier that separates athlete and observer, performance and life